0001209191-17-033755.txt : 20170518
0001209191-17-033755.hdr.sgml : 20170518
20170518201008
ACCESSION NUMBER: 0001209191-17-033755
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170516
FILED AS OF DATE: 20170518
DATE AS OF CHANGE: 20170518
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: QUIDEL CORP /DE/
CENTRAL INDEX KEY: 0000353569
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 942573850
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12544 HIGH BLUFF DRIVE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: 8585521100
MAIL ADDRESS:
STREET 1: 12544 HIGH BLUFF DRIVE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: MONOCLONAL ANTIBODIES INC /DE/
DATE OF NAME CHANGE: 19910210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SLACIK CHARLES P
CENTRAL INDEX KEY: 0001204660
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-10961
FILM NUMBER: 17856236
MAIL ADDRESS:
STREET 1: 250 S. KRAEMER BLVD
CITY: BREA
STATE: CA
ZIP: 92821
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-05-16
0
0000353569
QUIDEL CORP /DE/
QDEL
0001204660
SLACIK CHARLES P
12544 HIGH BLUFF DRIVE
SUITE 200
SAN DIEGO
CA
92130
1
0
0
0
Common Stock
2017-05-16
4
A
0
1111
0.00
A
1639
D
Common Stock
2017-05-17
4
M
0
962
0.00
A
2601
D
Restricted Stock Units (Premium)
2017-05-16
4
A
0
222
0.00
A
Common Stock
222
222
D
Restricted Stock Units (Equity Grant)
2017-05-16
4
A
0
2016
0.00
A
Common Stock
2016
2016
D
Non-Qualified Stock Options
24.80
2017-05-16
4
A
0
5065
0.00
A
2018-05-16
2027-05-16
Common Stock
5065
5065
D
The reporting person has received a fully vested stock payment award for shares of the Company's common stock in lieu of cash payments for certain retainer and Board of Director service-related fees under a 2017 compensation program applicable to participating non-employee directors.
Reflects vesting of prior restricted stock units, which were previously reported on a Form 4.
Each restricted stock unit represents the right to receive one share of Quidel Corporation common stock.
The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a 2017 compensation program applicable to participating non-employee directors. Vested restricted stock units may be deferred, in which case, payment will occur according to the elected deferral schedule.
The restricted stock units vest on the first anniversary date of the grant date, May 16, 2018.
Robert J. Bujarski, attorney-in-fact for Charles P. Slacik
2017-05-18